NCT03730324View on ClinicalTrials.gov

Predicting Prostate Biopsy Results With Biomarkers and mpMRI.

NACompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

June 1, 2022

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

mpMRI

Study subjects will undergo urine and plasma biomarker testing and mpMRI prior to biopsy

DIAGNOSTIC_TEST

Urine and plasma biomarkes.

Study subjects will undergo urine and plasma biomarker testing prior to standard biopsy

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Torben Brøchner Pedersen

OTHER

NCT03730324 - Predicting Prostate Biopsy Results With Biomarkers and mpMRI. | Biotech Hunter | Biotech Hunter